Abstract
Tigecycline is a broad-spectrum antibiotic with activity against multidrug-resistant (MDR) bacteria. It has limited indications. Studies are necessary to elaborate new guidelines. Here we report a case of postoperative MDR Acinetobacter baumannii meningitis treated by tigecycline combined with colimycin for 21 days. The treatment was well tolerated with a favourable outcome. In conclusion, tigecycline was shown to be effective in a case of MDR A. baumannii meningitis.
Author supplied keywords
Cite
CITATION STYLE
Kooli, I., Brahim, H. B., Kilani, M., Gannouni, C., Aouam, A., Toumi, A., … Chakroun, M. (2016). Successful treatment of postoperative multidrug-resistant Acinetobacter baumannii meningitis by tigecycline. Journal of Global Antimicrobial Resistance, 5, 62–63. https://doi.org/10.1016/j.jgar.2015.12.003
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.